MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+2.54%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$529M
AUM Growth
+$529M
(+0.03%)
Cap. Flow
+$35.3M
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
RAPT Therapeutics
RAPT
|
$35.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $334M | 63.2% | 19,963,157 | – | – |
|
2
NewAmsterdam Pharma
NAMS
$2.71B
| $73.7M | 13.94% | 2,869,565 | – | – |
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $60.6M | 11.46% | 7,464,572 | – | – |
|
|
4
RAPT Therapeutics
RAPT
$188M
| $35.3M | 6.68% | +22,352,000 | New | +$35.3M |
|
5
Aura Biosciences
AURA
$389M
| $25M | 4.72% | 3,039,892 | – | – |
|